Detalhe da pesquisa
1.
Prevalence and repair patterns of vesicovaginal fistula: a large retrospective population-based cohort analysis.
World J Urol;
42(1): 149, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38478136
2.
Safety and efficacy of an α1 -blocker plus mirabegron compared with an α1 -blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta-analysis.
Neurourol Urodyn;
43(3): 604-619, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38291827
3.
Stress Incontinence Surgery Does Not Cause Pelvic Malignancy: A Population-Based Cohort Study.
J Urol;
205(6): 1725-1732, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33829862
4.
What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine.
Neurourol Urodyn;
40(6): 1559-1568, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34036630
5.
Urinary retention after AdVance™ Sling: A multi-institutional retrospective study.
Neurourol Urodyn;
40(1): 515-521, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33348444
6.
Is There an Association between Urinary Incontinence and Mortality? A Retrospective Cohort Study.
J Urol;
203(3): 591-597, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31580760
7.
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS).
J Urol;
203(6): 1163-1171, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31895002
8.
Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR).
BMC Geriatr;
20(1): 109, 2020 03 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32183741
9.
Surgical treatment of post-prostatectomy stress urinary incontinence in adult men: Report from the 6th International Consultation on Incontinence.
Neurourol Urodyn;
38(1): 398-406, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30350875
10.
Long-term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study.
Neurourol Urodyn;
38(2): 779-792, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30644570
11.
The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction.
Neurourol Urodyn;
38(2): 433-477, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30681183
12.
Placenta percreta into the urinary bladder: the importance of the urologist.
Can J Urol;
26(2): 9736-9739, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31012839
13.
The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation.
Br J Cancer;
118(10): 1399-1405, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29593338
14.
Complications and Interventions in Patients with an Artificial Urinary Sphincter: Long-Term Results.
J Urol;
200(5): 1093-1098, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29940253
15.
Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients.
Neurourol Urodyn;
37(1): 394-406, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28704584
16.
Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).
Health Qual Life Outcomes;
16(1): 69, 2018 Apr 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29673355
17.
A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study).
Int Urogynecol J;
29(2): 273-283, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28620791
18.
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial.
J Urol;
197(2S): S216-S223, 2017 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28012773
19.
The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin Naïve Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double-Blind Phase 3b Trial.
J Urol;
198(1): 167-175, 2017 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28161352
20.
Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
BJU Int;
120(4): 562-575, 2017 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28418102